Comparison of the Efficacy and Safety of a Doravirine-Based, Three-Drug Regimen in Treatment-Naïve HIV-1 Positive Adults: A Bayesian Network Meta-Analysis

Introduction: Extensive use of antiretroviral therapy has remarkably improved the survival rates of people living with HIV. Doravirine (DOR) is a newly-approved antiretroviral belonging to the class of non-nucleoside reverse transcriptase inhibitors. Here, we compared the efficacy and safety of DOR...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ke Zhang, Yang Zhang, Jing Zhou, Lulu Xu, Chi Zhou, Guanzhi Chen, Xiaojie Huang
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2022-04-01
Edice:Frontiers in Pharmacology
Témata:
HIV
antiretroviral therapy
randomized controlled trials
doravirine
network meta-analysis
On-line přístup:https://www.frontiersin.org/articles/10.3389/fphar.2022.676831/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky